- Home
- SMTK vs NURO Comparison
SMTK vs NURO Comparison
Compare SMTK & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTK
- NURO
- Stock Information
- Founded
- SMTK 2009
- NURO 1996
- Country
- SMTK United Kingdom
- NURO United States
- Employees
- SMTK N/A
- NURO N/A
- Industry
- SMTK
- NURO Medical/Dental Instruments
- Sector
- SMTK
- NURO Health Care
- Exchange
- SMTK NYSE
- NURO Nasdaq
- Market Cap
- SMTK 9.5M
- NURO 7.6M
- IPO Year
- SMTK N/A
- NURO N/A
- Fundamental
- Price
- SMTK $2.45
- NURO $3.93
- Analyst Decision
- SMTK
- NURO
- Analyst Count
- SMTK 0
- NURO 0
- Target Price
- SMTK N/A
- NURO N/A
- AVG Volume (30 Days)
- SMTK 17.0K
- NURO 20.7K
- Earning Date
- SMTK 11-12-2024
- NURO 11-05-2024
- Dividend Yield
- SMTK N/A
- NURO N/A
- EPS Growth
- SMTK N/A
- NURO N/A
- EPS
- SMTK N/A
- NURO N/A
- Revenue
- SMTK $40,000.00
- NURO $3,767,764.00
- Revenue This Year
- SMTK N/A
- NURO N/A
- Revenue Next Year
- SMTK N/A
- NURO N/A
- P/E Ratio
- SMTK N/A
- NURO N/A
- Revenue Growth
- SMTK 471.43
- NURO N/A
- 52 Week Low
- SMTK $2.10
- NURO $2.66
- 52 Week High
- SMTK $13.00
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- SMTK N/A
- NURO 50.39
- Support Level
- SMTK N/A
- NURO $3.56
- Resistance Level
- SMTK N/A
- NURO $3.80
- Average True Range (ATR)
- SMTK 0.00
- NURO 0.32
- MACD
- SMTK 0.00
- NURO -0.01
- Stochastic Oscillator
- SMTK 0.00
- NURO 47.01
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.